GI
NRC icon

Gradient Investments’s NRC Health Common Stock NRC Stock Holding History

Gradient Investments’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13
Closed -$514 – 1624
2023
Q4 		$514 Hold
13
– – ﹤0.01% 1588
2023
Q3 		$577 Buy
+13
New +$567 ﹤0.01% 1520

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gradient Investments's NRC Position: Q1 2024 in Review

Gradient Investments sold out of NRC Health Common Stock (NRC) in Q1 2024, closing a stake of 13 shares — an estimated $514 sold.

Gradient Investments first reported a position in NRC in Q3 2023 and held it in 2 quarters. The position peaked at $577 in Q3 2023. 142 funds tracked by Wall St. Rank hold NRC as of Q1 2024.

  • Gradient Investments reported no remaining NRC Health Common Stock position as of Q1 2024 after selling out during the quarter.
  • Gradient Investments sold 13 NRC Health Common Stock shares in Q1 2024, an estimated $514.
  • Gradient Investments first reported a position in NRC Health Common Stock in Q3 2023 and held it in 2 quarters.
  • Gradient Investments's NRC Health Common Stock position peaked at $577 in Q3 2023.
  • 142 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2024.

Based on Gradient Investments's 13F filing for Q1 2024, filed 23 Apr 2024.